• Users Online: 8
  • Print this page
  • Email this page

Current Issue

October-December 2018| Vol 3| Issue 4

Clinical Registry Study

Comparing an internet-based medical model with a conventional medical model in the management of patients with hypertension in China: Methodology of a cluster randomized study

Background: The awareness, treatment, and control of hypertension are low in China. New and effective management model other than conventional hospital-based practices is needed to optimize t...


Review Article

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention

Cholesterol is a risk factor for atherosclerotic cardiovascular disease (ASCVD). The epidemiology, clinical intervention trials, and genetic studies that low-density lipoproteins (LDLs) cause ASCVD....


Research Article

Incidence of atrial fibrillation and risk factors analyzing in 126 cases of aortic surgery

Objective: This study aims to determine the current incidence of atrial fibrillation postaortic repair surgery and further identify its clinical predictors. Patients and Methods: Over ...


Research Article

The traditional Chinese medication nuanxin capsule aids in the treatment of chronic heart failure

Background: Nuanxin capsule is a standardized Chinese herbal medication that is commonly used alongside conventional treatment for chronic heart failure (CHF) in China. However, whether or no...


Guideline and Consensus

Recommendations for the clinical application of Angiotensin II receptor blocker in patients with coronary heart disease in 2018

Introduction The “China Cardiovascular Disease Report 2016”[1] reported that the number of people suffering from coronary heart disease in China is as high as 11 million,...


View All Articles in the Current Issue

Cardiology Plus, a publication of China Heart House, is a peer-reviewed print + online Quarterly journal.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, ProQuest, TdNet, Wanfang Data